Parakeratosis on Pap Smear: Clinical Significance
Parakeratosis found on an otherwise negative Pap smear warrants HPV testing and close follow-up, as it is associated with underlying squamous intraepithelial lesions (SIL) in approximately 30-40% of cases, though most are low-grade.
Risk Stratification and Evidence
The clinical significance of parakeratosis depends critically on whether it appears as an isolated finding or with other cellular abnormalities:
Isolated Parakeratosis (Otherwise Negative Pap)
When parakeratosis appears alone on a Pap smear:
- HPV positivity is significantly increased compared to smears without parakeratosis 1
- Low-grade SIL (LSIL) is found in approximately 30% of cases on subsequent evaluation 2
- High-grade SIL (HSIL) occurs in only 5-6% of cases 2, 3
- Invasive carcinoma is rare (0.4-1.8%) 2, 3
The most recent study 1 from 2017 analyzing over 22,000 Pap smears demonstrated that parakeratosis supports ordering HPV DNA testing as the next step, though the association with HSIL on biopsy did not reach statistical significance.
Age-Related Risk
Women under age 50 have higher rates of abnormalities (34% vs 19% in older women), primarily due to increased HPV-related changes 2. This age stratification should guide your follow-up intensity.
Critical Diagnostic Pitfall
Parakeratosis can mask underlying lesions and cause false-negative results. This is the most important clinical caveat:
- Cervical parakeratosis/hyperkeratosis was present in 87.8% of LSIL biopsies that had concurrent negative Pap tests 4
- These same cases showed an 83.3% HPV-negative rate, suggesting the keratinization obscures both cytologic and molecular detection 4
- When parakeratosis is extensive, it physically covers abnormal cells, preventing their detection
Recommended Management Algorithm
Based on the evidence and current cervical cancer screening guidelines 5:
Order HPV testing if not already performed (cotesting approach for women ≥30 years)
Repeat Pap smear in 6-12 months to ensure the parakeratosis resolves and no underlying lesion emerges
Consider colposcopy with directed biopsy if:
- HPV positive (especially HPV 16/18)
- Patient is under age 50 with persistent parakeratosis
- Any clinical cervical abnormality on examination
- Patient preference for definitive evaluation
If initial workup is negative: Continue routine screening per age-appropriate guidelines 5
Contradictory Evidence Note
One older study from 1990 6 found no increased incidence of CIN or HPV with isolated parakeratosis. However, this conflicts with multiple subsequent larger studies 1, 2, 3 showing 30-40% abnormality rates. The 1990 study had a smaller sample size (96 patients) and predated modern HPV testing methods, making it less reliable than recent evidence.
Clinical Context
While guidelines 5, 7 don't specifically address parakeratosis management (it's not part of the Bethesda System categories), the evidence clearly shows it represents an intermediate-risk finding requiring investigation rather than routine screening intervals. Treat parakeratosis as a "red flag" for potential underlying disease that may be masked, not as a benign incidental finding.
The key is recognizing that parakeratosis itself isn't dangerous, but it signals increased risk and can hide more serious pathology from detection.